As of 2026-01-07, the Relative Valuation of PTC Therapeutics Inc (PTCT) is 165.25 USD. This relative valuation is based on P/E multiples. With the latest stock price at 76.76 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is 115.3%.
The range of the Relative Valuation is 160.47 - 205.98 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.1x - 20.8x | 17.5x |
| Forward P/E multiples | 17.8x - 22.0x | 17.8x |
| Fair Price | 160.47 - 205.98 | 165.25 |
| Upside | 109.1% - 168.3% | 115.3% |
| Date | P/E |
| 2026-01-05 | 8.20 |
| 2026-01-02 | 8.20 |
| 2025-12-31 | 8.11 |
| 2025-12-30 | 8.14 |
| 2025-12-29 | 8.29 |
| 2025-12-26 | 8.39 |
| 2025-12-24 | 8.37 |
| 2025-12-23 | 8.30 |
| 2025-12-22 | 8.43 |
| 2025-12-19 | 8.39 |
| 2025-12-18 | 7.97 |
| 2025-12-17 | 8.00 |
| 2025-12-16 | 8.06 |
| 2025-12-15 | 8.14 |
| 2025-12-12 | 8.08 |
| 2025-12-11 | 8.06 |
| 2025-12-10 | 7.91 |
| 2025-12-09 | 7.85 |
| 2025-12-08 | 8.21 |
| 2025-12-05 | 8.25 |
| 2025-12-04 | 8.31 |
| 2025-12-03 | 8.09 |
| 2025-12-02 | 8.38 |
| 2025-12-01 | 8.46 |
| 2025-11-28 | 9.18 |
| 2025-11-26 | 9.21 |
| 2025-11-25 | 8.86 |
| 2025-11-24 | 8.53 |
| 2025-11-21 | 8.38 |
| 2025-11-20 | 8.17 |
| 2025-11-19 | 8.07 |
| 2025-11-18 | 8.19 |
| 2025-11-17 | 8.07 |
| 2025-11-14 | 8.04 |
| 2025-11-13 | 8.01 |
| 2025-11-12 | 8.01 |
| 2025-11-11 | 7.88 |
| 2025-11-10 | 7.74 |
| 2025-11-07 | 7.67 |
| 2025-11-06 | 7.75 |
| 2025-11-05 | 7.67 |
| 2025-11-04 | 7.23 |
| 2025-11-03 | 7.26 |
| 2025-10-31 | 7.30 |
| 2025-10-30 | 7.27 |
| 2025-10-29 | 7.19 |
| 2025-10-28 | 7.21 |
| 2025-10-27 | 7.16 |
| 2025-10-24 | 7.09 |
| 2025-10-23 | 7.13 |